APPLICATIONS PUBLISHED 28 JANUARY 2004
Published: 1-Aug-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops
HF Arzneimittelforschung 1383503*
Sustained release drug delivery system containing codrugs
Control Delivery Systems 1383504*
Inosine compounds and their use for treating or preventing an inflammation or a reperfusion disease
Inotek Pharmaceuticals 1383505*
Fused heterocyclic inhibitors of phosphodiesterase (PDE) 7
Bristol-Myers Squibb 1383506*
Utilisation of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances
HF Arzneimittelforschung 1383507*
Methods of treating acne
Collagenex Pharmaceuticals 1383508*
A drug for use in bone grafting
The Royal Alexandra Hospital for Children 1383509*
Bisphosphonate conjugates and methods of making and using the same
MBC Research 1383510*
Calcilytic compounds
SmithKline Beecham 1383511*
Use of sucralfate for the treatment of cervical erosion
Farmigea 1383512*
Tumour therapy with alphavirus-based and high affinity laminin receptor-targeted vectors
New York University 1383513*
Compsn comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters
Societe des Produits Nestle 1383514*
Activation of natural killer cells by adenosine A3 receptor agonists
Can-Fite Biopharma 1383515*
Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
Pro-Pharmaceuticals 1383516*
Use of cationic dextran derivatives for protecting dose-limiting organs
Map Medical Technologies 1383517*
Oral delivery of macromolecules
Mediplex Corp 1383518*
Treatment solution used for caring for wounds in addition to dressing material for use with said treatment solution
Nawa-Heilmittel; Reisinger, Thomas 1383519*
Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
Nucryst Pharmaceuticals 1383520*
Medicament containing a metal such as solver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
Nucryst Pharmaceuticals 1383521*
A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions
Nucryst Pharmaceuticals 1383522*
Agent for treating diabetes mellitus
Lichtwer Pharma 1383523*
Method for purifying a biological compsn
VI Technologies 1383524*
Nutritional supplement to alleviate levels of stress and reduced levels of serotonin
Advanced Functional Foods 1383525*
Peptide-based immunisation therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidised low-density lipoprotein
Forskapatent; Cedars Sinai Medical Centre 1383526*
Methods and compsns for treating oral and esophageal lesions
The General Hospital Corp 1383527*
Epitope sequences
Mennkind Corp 1383528*
Methods of treating disorders of the eye and surrounding tissue with thymosin 4 (T4) analogues, isoforms and other derivatives
Regenerx Biopharmaceuticals 1383529*
Laminin 5, 13 and 14 and uses thereof
The General Hospital Corp; Trustees of Tufts College 1383530*
Use of LP82 to treat hematopoietic disorders
Eli Lilly 1383531*
Combination therapy
Genentech 1383532*
Proteins and nucleic acids encoding same
Curagen Corp; Millennium Pharmaceuticals 1383533*
Chlamydia vaccine compsn
GlaxoSmithKline Biologicals 1383534*
